All filters
Videos
Time to First Positive HIV-1 DNA PCR in Infants Infected with Subtype B HIV-1 is Delayed in the Presence of Maternal Antiretroviral Use - Raji Balasubramanian
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Children Who are HIV-Exposed and Uninfected Exhibit Immune Suppressive Plasma Biomarker Profiles - Alka Khaitan
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Extent of In Utero Transfer of Tenofovir from Mother to Fetus: A Paired Analysis of Hair Specimens Collected at Birth from a Cohort in the United States - Jillian Pintye
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Use of a Walk-In HIV and STI Testing Model for at Risk Youth Ages 13 to 24 - Assessment of the Impact of the COVID-19 Pandemic on Testing Services - Isabella Lopez
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
A Multi-Country Analysis of the Impact of COVID-19 on HIV Services for Pregnant and Breastfeeding Women and their Infants - Alexandra Vrazo
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
A Multi-Country Analysis of the Impact of COVID-19 on Uptake of Multi-Month Dispensing for Children Living with HIV on Antiretroviral Therapy - Nimasha Fernando
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Challenges of Remdesivir Pediatric Development for SARS-Cov-2 Infection in a Pandemic - Cheryl Pikora
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Session 6: Oral Abstract Session 5 - Prevention of HIV Mother-to-Child Transmission
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
A Multi-Country Analysis of the Impact of COVID-19 on HIV Services for Children and Adolescents Living with HIV - Ariana Traub
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Session 6: Oral Abstract Session 4 - COVID-19 in Children
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Session 6: Oral Abstract Session 3 - Adolescents and HIV
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Twenty-Four Week Safety, Tolerability and Efficacy of Dolutegravir Dispersible Tablets in Children 4 Weeks to <6 Years Old with HIV: Results from IMPAACT P1093 - Theodore Ruel
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Session 5: Pediatrics Session - Q&A
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Prevention of Mother To Child HIV Transmission - Global Gaps and Potential Solutions - Benjamin Chi
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
PrEP in Pregnancy and Breastfeeding: the Why, What and How - Jillian Pintye
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Guided Poster Tour 4: Pediatrics HIV Care and Monitoring
Presented at:
International Workshop on HIV Pediatrics 2020
Videos
Guided Poster Tour 3: Prevention of Mother-to-Child HIV Transmission
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Twenty-four week safety, tolerability and efficacy of dolutegravir dispersible tablets in children 4 weeks to <6 years old with HIV: results from IMPAACT P1093
T. Ruel
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Pediatric dolutegravir (DTG) dosing recommendations derived from combined P1093 and ODYSSEY Population Pharmacokinetic analysis
R. Singh
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Safety, pharmacokinetics, and efficacy of low-dose E/C/F/TAF in virologically suppressed children ≥2 years old living with HIV
E. Natukunda
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Safety, pharmacokinetics and acceptability of the ABC/3YC/LPV/R granules (4-in-1) in children living with HIV (3-20kg) in Uganda: LOLIPOP study
J. Mwanga-Amumpaire
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Acceptability of a new 4-in-1 Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed-dose combination: the caregiver-child dyads’ perspective
A. Rotsaert
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020